BioSpace News Archive

Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that the company will host a conference call and live webcast on Thursday, August 13, 2020 at 5:00 p.m. ET to report second quarter 2020 financial results and discuss recent business highlights.

Apollo Endosurgery, Inc. today announced that the Company is scheduled to release its financial results for the second quarter ended June 30, 2020 on Tuesday, August 4, 2020, after the U.S. stock markets close.

REDWOOD CITY, CA / ACCESSWIRE / July 30, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today reported results for the second quarter ended June 30, 2020. Second Quarter and Recent Highlights Reported total revenue of $1.5 million, a decrease from the prior year and previous quarter due to the effects of

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its second-quarter 2020 financial results and recent business highlights after the close of the U.S. financial markets on Wednesday, August 5, 2020.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the second quarter ended June 30, 2020.

Geron Corporation (Nasdaq: GERN) today announced that it will release its second quarter 2020 financial results after the market closes on Thursday, August 6, 2020 via press release, which will be available on the Company’s website at www.geron.com/investors.

Halodine LLC announces collaboration with Emery Pharma, a boutique contract research and development company, to advance the development of Halodine’s proprietary antiseptic platform for COVID-19.

Select Medical Holdings Corporation (“Select Medical,” “we,” “us,” or “our”) (NYSE: SEM) today announced results for its second quarter ended June 30, 2020.

Endo International plc (NASDAQ: ENDP) today announced that it has changed the time of its previously announced conference call in an attempt to reduce conflicts with other earnings calls.

Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com (“Liberty” or the “Company”), a provider of high-quality cannabis, announced its financial results for the first quarter ended May 31, 2020. Consolidated net sales for the quarter ended May 31, 2020 were $18,440,756, compared with $5,520,561 for the quarter ended May 31, 2019.